Dr. Ping Zhang Appointed as Tenure Track Investigator

Posted: Aug 25, 2016

Ping Zhang, Ph.D. has been appointed as a Stadtman Tenure Track Investigator in the Structural Biophysics Laboratory (SBL).  Dr. Zhang’s expertise is in the fields of X-ray crystallography and cryoEM for the study of multicomponent complexes relevant to cancer and human disease. Her program is expected to be synergistic with the existing program with the SBL and to expand the expertise into the rapidly developing area of cryoEM investigation of proteins and protein-complexes.

Dr. Ping Zhang Appointed as Tenure Track Investigator

Waldmann Discusses the "The Second Coming of Daclizumab"

Posted: Aug 24, 2016

Dr. Waldmann, NIH Distinguished Investigator and Chief of the Lymphoid Malignancies Branch, discusses his 35-year odyssey with daclizumab.
Read more...

Waldmann Discusses the "The Second Coming of Daclizumab"

Blood-Brain Barrier: The "Holy Grail' of Neuro-oncology

Posted: Aug 24, 2016

"People like me say…we need to find a way…"  Sadhana Jackson, a physician researcher with the Neuro-Oncology Branch, discusses the challenges of delivering drug treatments to brain tumors in an interview with HemOnc Today. Read More...

Blood-Brain Barrier: The "Holy Grail' of Neuro-oncology

Dr. Ramaprasad Srinivasan Appointed as Tenure Track Investigator

Posted: Aug 23, 2016

Ramaprasad Srinivasan, M.D., Ph.D., has been appointed as a Tenure Track Investigator in the Urologic Oncology Branch. Dr. Srinivasan is a recognized expert in genitourinary oncology, notably in targeted therapeutic approaches for patients with advanced forms of renal cell carcinoma. His research focuses on developing and conducting clinical trials using molecular treatment approaches targeting kidney cancer pathways and targeted therapeutic agents in patients with localized and advanced forms of kidney cancer. He is currently investigating a variety of newer targeted agents in clear cell and papillary kidney cancer, as well as hereditary kidney cancer syndromes, such as von Hippel-Lindau, hereditary leiomyomatosis, and renal cell cancer and hereditary papillary renal cell cancer.

Dr. Ramaprasad Srinivasan Appointed as Tenure Track Investigator

Seeking to Unlock the Genomic Keys to Ovarian Cancer

Posted: Aug 22, 2016

CCR’s Tina Annunziata, physician scientist with the Women’s Malignancies Branch discusses genomic profiling in ovarian cancer in an interview in OncLive Read more...

Seeking to Unlock the Genomic Keys to Ovarian Cancer

Faith, Hope, and Determination Help Teenager Fight A Rare Cancer

Posted: Aug 19, 2016

Our clinical research is not possible without exceptional people like teenager, Terran Dupree, who is enrolled on a mesothelioma clinical trial in CCR’s Pediatric Oncology Branch. Physician-scientist Rosie Kaplan calls Terran “a strong, beautiful young lady with a big open heart.”   Read More...

Faith, Hope, and Determination Help Teenager Fight A Rare Cancer

Clinical Trials on Pets Moving Cancer Research Forward

Posted: Aug 19, 2016

Science magazine profiled CCR’s Comparative Oncology Program, which coordinates a nationwide network of veterinary oncologists running clinical trials with pet animals suffering with cancer. Read More...

Clinical Trials on Pets Moving Cancer Research Forward

New Immunotherapy Gives Tumor-Fighting Immune Cells the Chance to Attack

Posted: Aug 18, 2016

Scientists at the National Cancer Institute’s Center for Cancer Research have empowered the immune systems of mice to rid their bodies of tumors with a new kind of immunotherapy.

New Immunotherapy Gives Tumor-Fighting Immune Cells the Chance to Attack

Tanner Named as One of the 2016 Young Innovators of Cellular and Molecular Bioengineering

Posted: Aug 17, 2016

Kandice Tanner was selected as one of the 2016 Cellular and Molecular Bioengineering (CMBE) Young Innovators. She will present her work on the mechanical properties of the tumor stromal microenvironment at the 2016 Annual Biomedical Engineering Society Meeting in Minneapolis, Minnesota on October 5–8, 2016.

Tanner Named as One of the 2016 Young Innovators of Cellular and Molecular Bioengineering

Pages